In the DLBCLs series, MYC-R was detected in 21 out of 85 DLBCL patients, BCL2-R in 10 out of 85 and BCL6-R in 33 out of 85 (Table 1). Here, BCL2 is linked to diffuse large B-cell lymphoma.